Free Trial
Mitchell S.

Mitchell S. Analyst Performance

Biotech Analyst at HC Wainwright

Mitchell S. is a stock analyst at HC Wainwright in the medical sector, covering 18 publicly traded companies. Over the past year, Mitchell S. has issued 28 stock ratings, including buy, hold, and sell recommendations. While full access to Mitchell S.'s proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Mitchell S.'s coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
28 Last 0 Years
Buy Recommendations
89.29% 25 Buy Ratings
Companies Covered
18 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy89.3%25 ratings
Hold7.1%2 ratings
Sell3.6%1 ratings

Out of 28 total stock ratings issued by Mitchell S. at HC Wainwright, the majority (89.3%) have been Buy recommendations, followed by 7.1% Hold and 3.6% Sell.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
18 companies

Mitchell S., an analyst at HC Wainwright, currently covers 18 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
18 companies
100.0%

Mitchell S. of HC Wainwright specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
11 companies
61.1%
MED - DRUGS
7 companies
38.9%

Mitchell S.'s Ratings History at HC Wainwright

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
9/23/2025Reiterated Rating$62.10$80.00Buy
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
9/23/2025Reiterated Rating$61.36$95.00Buy
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
9/22/2025Boost Price Target$77.81$85.00Buy
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
9/19/2025Boost Price Target$16.11$30.00Buy
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
9/16/2025Reiterated Rating$18.94$50.00Buy
Instil Bio, Inc. stock logo
TIL
Instil Bio
9/11/2025Reiterated Rating$24.16$125.00Buy
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
9/8/2025Reiterated Rating$25.98$50.00Buy
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
9/8/2025Initiated Coverage$57.77$60.00Neutral
Editas Medicine, Inc. stock logo
EDIT
Editas Medicine
9/5/2025Reiterated Rating$2.52$5.00Buy
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
9/2/2025Reiterated Rating$23.70$50.00Buy
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
9/2/2025Boost Price Target$42.63$95.00Buy
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
8/27/2025Boost Price Target$26.98$50.00Buy
Crescent Biopharma, Inc. stock logo
CBIO
Crescent Biopharma
8/27/2025Reiterated Rating$14.47$25.00Buy
Instil Bio, Inc. stock logo
TIL
Instil Bio
8/27/2025Reiterated Rating$28.41$125.00Buy
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
8/25/2025Reiterated Rating$20.22Sell
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
8/22/2025Boost Price Target$43.24$70.00Buy
Tyra Biosciences, Inc. stock logo
TYRA
Tyra Biosciences
8/22/2025Reiterated Rating$11.70$30.00Buy
Metagenomi, Inc. stock logo
MGX
Metagenomi
8/19/2025Reiterated Rating$1.92$7.00Buy
Zura Bio Limited stock logo
ZURA
Zura Bio
8/19/2025Lower Price Target$1.74$2.00Neutral
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
8/18/2025Reiterated Rating$15.37$45.00Buy
Lexeo Therapeutics, Inc. stock logo
LXEO
Lexeo Therapeutics
8/15/2025Lower Price Target$4.79$9.00Buy
Instil Bio, Inc. stock logo
TIL
Instil Bio
8/15/2025Reiterated Rating$28.25$125.00Buy
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
8/15/2025Reiterated Rating$26.45$44.00Buy
Alumis Inc. stock logo
ALMS
Alumis
8/14/2025Reiterated Rating$4.42$14.00Buy
Korro Bio, Inc. stock logo
KRRO
Korro Bio
8/13/2025Lower Price Target$15.99$90.00Buy
Crescent Biopharma, Inc. stock logo
CBIO
Crescent Biopharma
8/11/2025Initiated Coverage$12.85$25.00Buy
Boundless Bio, Inc. stock logo
BOLD
Boundless Bio
8/11/2025Lower Price Target$1.10$4.00Buy
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
8/8/2025Lower Price Target$11.46$25.00Buy